The White House has launched a commission to fight drug addiction that will be chaired by New Jersey Governor Chris Christie, who for years has spoken out on drug abuse, according to an article in the Washington Post. President Trump established the “President’s Commission to Combat Drug Addiction and the Opioid Crisis” by executive order.

The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a nonprofit effort based in Boston, is investing $24 million immediately and up to $24 million in milestone-based additional payments over three years to help 11 biotech companies and research teams accelerate the development of new antibacterials and diagnostics aimed at

A study published in the American Journal of Respiratory and Critical Care Medicine describes a new treatment pathway for antibiotic-resistant bacteria and infectious diseases with benefits for patients and health care providers alike.

There’s a chance that health care insurers participating in the ACA exchanges might continue to get the billions of dollars in government subsidies that has made that participation possible.

There’s a new skipper at the helm of GlaxoSmithKline, and she takes over in the wake of lackluster growth in recent years and some uncertainty as to just what course the company needs to chart to get back to its vigorous old self.

Humana says that 50,000 of its employees are ahead of schedule when it comes to achieving their wellness goals, according to a Humana progress report. The company’s wellness program, Bold Goal, set certain benchmarks it wants participating employees to reach by 2020.

In testimony before House appropriators, Health and Human Services (HHS) Secretary Tom Price has stated that the Trump administration is still determined to dismantle parts of the Patient Protection and Affordable Care Act (PPACA) even if Republicans lack the votes to rewrite it, according to an article in the Washington Post.

Psychiatric services are in a state of crisis in the United States, and stakeholders in the health care industry have roles to play in fixing the problem, according to a report from the National Council for Behavioral Health (NCBH).

The FDA’s Oncologic Drugs Advisory Committee has voted unanimously (11 to 0) that the risk–benefit ratio of rituximab/hyaluronidase for subcutaneous (SC) injection (Halozyme Therapeutics) was favorable for patients in the proposed indications of follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia.

Fewer than one in 10 Americans believe it is likely that they will be infected by the Zika virus, according to a recent Gallup poll.

Mylan has reported on the status of its abbreviated new drug application with the FDA for its generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder). The company states that it has received a complete response letter (CRL) from the FDA and is in the process of reviewing the agency’s comments.

Physicians (and most others in health care) learn early that you need to remain somewhat emotionally detached from patients’ struggles if you want to render the best care. Clinical clear-sightedness is crucial.

The FDA has greenlighted ocrelizumab (Ocrevus, Genentech) as the first medication for both relapsing and primary progressive forms of multiple sclerosis (RMS/PPMS). Most MS patients have RMS or PPMS at diagnosis.

President Trump has told a group of senators that he expects lawmakers will be able to reach a deal on health care, without offering specifics on how they would do it or what had changed since a Republican-backed plan to reform the Patient Protection and Affordable Care Act (PPACA) was withdrawn from a House vote last week because of insufficient support.

President Trump’s administration has proposed cutting $1.23 billion this fiscal year from research funded by the National Institutes of Health (NIH), according to a report from Bloomberg Politics. The reduction is part of $18 billion in cuts that the administration wants in fiscal 2017, which ends in October.